Literature DB >> 31748820

Diverting loop ileostomy with colonic lavage as an alternative to colectomy for fulminant Clostridioides difficile: a systematic review and meta-analysis.

Tyler McKechnie1,2, Yung Lee1,2, Jeremy E Springer2, Aristithes G Doumouras2,3, Dennis Hong2,3, Cagla Eskicioglu4,5.   

Abstract

PURPOSE: Surgical consultation is recommended for all patients with fulminant Clostridioides difficile infection (CDI). If surgery is required, total abdominal colectomy (TAC) is most commonly performed. However, diverting loop ileostomy and colonic lavage have been recently developed as a potential colon-sparing approach to fulminant CDI. The aim of this review is to compare TAC and diverting loop ileostomy with colonic lavage for fulminant CDI.
METHODS: Search of MEDLINE, EMBASE, CENTRAL, and PubMed was performed. Articles were eligible for inclusion if they compared TAC and diverting loop ileostomy with colonic lavage. The primary outcome was postoperative mortality, and the secondary outcome was postoperative complications. Quality of included studies was assessed using Newcastle-Ottawa Scale.
RESULTS: From 64 relevant citations, 5 studies (4 retrospective cohorts, 1 case series) with 3683 patients were included. Compared to TAC, diverting loop ileostomy with colonic lavage did not significantly reduce overall mortality (RR 1.10, 95% CI 0.60 to 1.99, P = 0.77), rate of reoperation (RR 1.02, 95% CI, 0.63 to 1.63, P = 0.94), or overall postoperative complications (RR 0.51, 95% CI, 0.22 to 1.17, P = 0.11). Rates of colonic preservation with the use of diverting loop ileostomy with colonic lavage ranged from 76% to 100%.
CONCLUSION: There does not appear to be a survival advantage with the use of diverting loop ileostomy with colonic lavage compared to TAC for fulminant CDI. However, diverting loop ileostomy with colonic lavage results in increased rates of colonic preservation, restoration of intestinal continuity, and laparoscopic surgery. This review is limited by the small number of included studies.

Entities:  

Keywords:  Antegrade colonic lavage; Clostridioides difficile; Loop ileostomy; Minimally invasive surgery; Total abdominal colectomy

Year:  2019        PMID: 31748820     DOI: 10.1007/s00384-019-03447-3

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  30 in total

1.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  Ann Intern Med       Date:  2009-07-20       Impact factor: 25.391

2.  Fulminant Clostridium difficile colitis: prospective development of a risk scoring system.

Authors:  Gwendolyn M van der Wilden; Yuchiao Chang; Catrina Cropano; Melanie Subramanian; Inger B Schipper; D Dante Yeh; David R King; Marc A de Moya; Peter J Fagenholz; George C Velmahos
Journal:  J Trauma Acute Care Surg       Date:  2014-02       Impact factor: 3.313

Review 3.  Practice parameters for the management of Clostridium difficile infection.

Authors:  Scott R Steele; James McCormick; Genevieve B Melton; Ian Paquette; David E Rivadeneira; David Stewart; W Donald Buie; Janice Rafferty
Journal:  Dis Colon Rectum       Date:  2015-01       Impact factor: 4.585

4.  No survival advantage exists for patients undergoing loop ileostomy for clostridium difficile colitis.

Authors:  Bradley R Hall; Jennifer A Leinicke; Priscila R Armijo; Lynette M Smith; Sean J Langenfeld; Dmitry Oleynikov
Journal:  Am J Surg       Date:  2018-09-22       Impact factor: 2.565

5.  Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease.

Authors:  Matthew D Neal; John C Alverdy; Daniel E Hall; Richard L Simmons; Brian S Zuckerbraun
Journal:  Ann Surg       Date:  2011-09       Impact factor: 12.969

6.  Postoperative complications and mortality following colectomy for ulcerative colitis.

Authors:  Shanika de Silva; Christopher Ma; Marie-Claude Proulx; Marcelo Crespin; Belle S Kaplan; James Hubbard; Martin Prusinkiewicz; Andrew Fong; Remo Panaccione; Subrata Ghosh; Paul L Beck; Anthony Maclean; Donald Buie; Gilaad G Kaplan
Journal:  Clin Gastroenterol Hepatol       Date:  2011-07-30       Impact factor: 11.382

7.  Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.

Authors:  Stuart Johnson; Thomas J Louie; Dale N Gerding; Oliver A Cornely; Scott Chasan-Taber; David Fitts; Steven P Gelone; Colin Broom; David M Davidson
Journal:  Clin Infect Dis       Date:  2014-05-05       Impact factor: 9.079

8.  C. difficile colitis--predictors of fatal outcome.

Authors:  Haig Dudukgian; Ester Sie; Claudia Gonzalez-Ruiz; David A Etzioni; Andreas M Kaiser
Journal:  J Gastrointest Surg       Date:  2010-02       Impact factor: 3.452

9.  Severe Clostridium difficile colitis.

Authors:  M S Rubin; L E Bodenstein; K C Kent
Journal:  Dis Colon Rectum       Date:  1995-04       Impact factor: 4.585

10.  Predictive factors of mortality after colectomy in ischemic colitis: an ACS-NSQIP database study.

Authors:  Joshua Tseng; Brandi Loper; Monica Jain; Azaria V Lewis; Daniel R Margulies; Rodrigo F Alban
Journal:  Trauma Surg Acute Care Open       Date:  2017-11-02
View more
  1 in total

1.  Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).

Authors:  E Bouza; J M Aguado; L Alcalá; B Almirante; P Alonso-Fernández; M Borges; J Cobo; J Guardiola; J P Horcajada; E Maseda; J Mensa; N Merchante; P Muñoz; J L Pérez Sáenz; M Pujol; E Reigadas; M Salavert; J Barberán
Journal:  Rev Esp Quimioter       Date:  2020-02-20       Impact factor: 1.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.